US to provide Bavarian Nordic’s vaccine Jynneos to some at risk for monkeypox, CDC saysnews2022-05-24T19:30:49+00:00May 24th, 2022|Fierce Pharma|
GSK ‘schemed’ FDA’s drug-device approval pathway to deflect asthma inhaler generics, lawsuit claimsnews2022-05-24T19:12:59+00:00May 24th, 2022|Fierce Pharma|
Bristol’s Abecma, Amgen’s Lumakras headline record-setting oncology launch class as costs continue to balloon: IQVIAnews2022-05-24T15:43:38+00:00May 24th, 2022|Fierce Pharma|
Moderna CEO Bancel uses inaugural stock option to give $355M to charitynews2022-05-24T15:15:57+00:00May 24th, 2022|Fierce Pharma|
In bankruptcy case, U.S. wants court to block J&J’s use of high-powered, highly paid lawyer Neal Katyalnews2022-05-24T15:14:32+00:00May 24th, 2022|Fierce Pharma|
In bankruptcy case, US wants court to block J&J’s use of high-powered, highly paid lawyer Neal Katyalnews2022-05-24T15:14:32+00:00May 24th, 2022|Fierce Pharma|
Kala buys time by selling eye disease drugs to Alcon for $60Mnews2022-05-24T14:26:12+00:00May 24th, 2022|Fierce Pharma|
J&J’s crown jewel Stelara faces another potential rival as biosim player Alvotech touts trial winnews2022-05-24T14:17:17+00:00May 24th, 2022|Fierce Pharma|
With inhaled version of Tyvaso, United Therapeutics sniffs a potential blockbusternews2022-05-24T13:44:53+00:00May 24th, 2022|Fierce Pharma|
Zealand pumps up its prospects with late-phase rare disease hitnews2022-05-24T13:32:26+00:00May 24th, 2022|Fierce Pharma|
